Health
Mouse-adapted SARS-CoV-2 model helps advance the development of COVID-19 vaccines – News-Medical.Net
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Reviewed by Emily Henderson, B.Sc.Aug 27 2020
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Researchers, among them virologists and microbiologists at UNC-Chapel Hill’s Gillings School of Global Public Health, describe the mouse-adapted SARS-CoV-2 model in a paper fast-tracked and published Aug. 27 in Nature.
Small animal models that r…
-
Noosa News14 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business19 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General20 hours agoRush to buy homes before rate cuts send prices soaring
-
Business16 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025